NMR spectroscopic studies on the late onset form of 3‐methylglutaconic aciduria type I and other defects in leucine metabolism

NMR in Biomedicine
2006.0

Abstract

<jats:title>Abstract</jats:title><jats:p>A diagnosis of 3‐methylglutaconic aciduria type I (OMIM: 250950) based on elevated urinary excretion of 3‐methylglutaconic acid (3MGA), 3‐methylglutaric acid (3MG) and 3‐hydroxyisovaleric acid (3HIVA) was made in a 61‐year‐old female patient presenting with leukoencephalopathy slowly progressing over more than 30 years. The diagnosis was confirmed at the enzymatic and molecular level. <jats:italic>In vivo</jats:italic> brain MR spectroscopic imaging (MRSI) was performed at 3.0 T, and one‐dimensional and two‐dimensional <jats:italic>in vitro</jats:italic> NMR spectroscopy of body fluids of the patient was performed at 11.7 T. Additionally, we measured 1D <jats:sup>1</jats:sup>H‐NMR spectra of urine of seven patients with a total of four different inborn errors of leucine metabolism. Increased concentrations of 3HIVA, 3MGA (<jats:italic>cis</jats:italic> and <jats:italic>trans</jats:italic>) and 3MG were observed in the NMR spectra of the patient's urine. In the cerebrospinal fluid, the 3HIVA concentration was 10 times higher than in the plasma of the patient and only the <jats:italic>cis</jats:italic> isomer of 3MGA was observed. <jats:italic>In vivo</jats:italic> brain MRSI showed an abnormal resonance at 1.28 ppm that may be caused by 3HIVA. Comparison of <jats:sup>1</jats:sup>H‐NMR spectra of urine samples from all eight patients studied, representing five different inborn errors of leucine metabolism, showed that each disease has typical NMR characteristics. Our leukoencephalopathy patient suffers from a late‐onset form of 3‐methylglutaconic aciduria type I. In the literature, only very few adult patients with this conditions have been described, and 3HIVA accumulation in white matter in the brain has not been presented before in these patients. Our data demonstrate that <jats:sup>1</jats:sup>H‐NMR spectroscopy of urine can easily discriminate between the known inborn errors of leucine metabolism and provide the correct diagnosis. Copyright © 2006 John Wiley &amp; Sons, Ltd.

Knowledge Graph

Similar Paper

NMR spectroscopic studies on the late onset form of 3‐methylglutaconic aciduria type I and other defects in leucine metabolism
NMR in Biomedicine 2006.0
Sensitivity and specificity of free and total glutaric acid and 3‐hydroxyglutaric acid measurements by stable‐isotope dilution assays for the diagnosis of glutaric aciduria type I
Journal of Inherited Metabolic Disease 1999.0
Brain MRI Findings as an Important Diagnostic Clue in Glutaric Aciduria Type 1
The Neuroradiology Journal 2013.0
A gas chromatographic—mass spectrometric study of profiles of volatile metabolites in hepatic encephalopathy
Journal of Chromatography B: Biomedical Sciences and Applications 1981.0
<i>In vivo</i> and <i>in vitro</i> nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of <sup>1</sup>H and <sup>31</sup>P MRS applications
Liver International 2005.0
Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine
Kidney International 2011.0
Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children
NMR in Biomedicine 2005.0
600 MHz 1H-NMR spectroscopy of human cerebrospinal fluid: Effects of sample manipulation and assignment of resonances
Journal of Pharmaceutical and Biomedical Analysis 1993.0
3‐Hydroxyglutarate excretion is increased in ketotic patients: Implications for glutaryl‐CoA dehydrogenase deficiency testing
Journal of Inherited Metabolic Disease 2002.0
Simultaneous high performance liquid chromatographic separation of purines, pyrimidines, N-acetylated amino acids, and dicarboxylic acids for the chemical diagnosis of inborn errors of metabolism
Clinical Biochemistry 2005.0